Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine.
| Autor: | Khan, Saif1 (AUTHOR) sf.khan@uoh.edu.sa, Jandrajupalli, Suresh Babu2 (AUTHOR) s.jandrajupalli@uoh.edu.sa, Bushara, Nashwa Zaki Ali2 (AUTHOR) n.bushara@uoh.edu.sa, Raja, Rama Devi Patel3 (AUTHOR) r.patel@uoh.edu.sa, Mirza, Shadab1 (AUTHOR) s.mirza@uoh.edu.sa, Sharma, Kuldeep4 (AUTHOR) kuldeep.sharma@chitkara.edu.in, Verma, Rajan5 (AUTHOR) rajan1708verma@gmail.com, Kumar, Ashish6,7 (AUTHOR) ashishrahul79@gmail.com, Lohani, Mohtashim8 (AUTHOR) mlohani@jazanu.edu.sa |
|---|---|
| Zdroj: | Cells (2073-4409). Dec2024, Vol. 13 Issue 24, p2126. 26p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|